UBS AM’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $6.27M | Sell |
|
|||||
|
2023
Q4 | $6.45M | Sell |
|
|||||
|
2023
Q3 | $5.12M | Sell |
|
|||||
|
2023
Q2 | $6.43M | Hold |
|
|||||
|
2023
Q1 | $6.43M | Buy |
|
|||||
|
2022
Q4 | $589K | Sell |
|
|||||
|
2022
Q3 | $974K | Buy |
|
|||||
|
2022
Q2 | $664K | Buy |
|
|||||
|
2022
Q1 | $414K | Hold |
|
|||||
|
2021
Q4 | $436K | Sell |
|
|||||
|
2021
Q3 | $12.2M | Sell |
|
|||||
|
2021
Q2 | $14.4M | Buy |
|
|||||
|
2021
Q1 | $12.8M | Sell |
|
|||||
|
2020
Q4 | $22.2M | Buy |
|
|||||
|
2020
Q3 | $14.5M | Buy |
|
|||||
|
2020
Q2 | $16.2M | Sell |
|
|||||
|
2020
Q1 | $11.7M | Sell |
|
|||||
|
2019
Q4 | $19.4M | Buy |
|
|||||
|
2019
Q3 | $7.7M | Buy |
|